Total Payments
$26,312
2024 Payments
$1,914
Companies
37
Transactions
252
Medicare Patients
2,368
Medicare Billing
$144,606
Payment Breakdown by Category
Consulting$12,000 (45.6%)
Travel$7,626 (29.0%)
Food & Beverage$6,555 (24.9%)
Education$131.45 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $12,000 | 5 | 45.6% |
| Travel and Lodging | $7,626 | 17 | 29.0% |
| Food and Beverage | $6,555 | 225 | 24.9% |
| Education | $131.45 | 5 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Edap Technomed Inc | $20,352 | 33 | $0 (2024) |
| Teleflex LLC | $810.59 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $716.98 | 31 | $0 (2024) |
| Astellas Pharma US Inc | $536.97 | 18 | $0 (2024) |
| PROCEPT BioRobotics Corporation | $399.80 | 5 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $371.55 | 20 | $0 (2024) |
| ABBVIE INC. | $328.00 | 12 | $0 (2024) |
| PFIZER INC. | $309.71 | 15 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $281.43 | 8 | $0 (2024) |
| UROGEN PHARMA, INC. | $208.10 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,914 | 71 | Edap Technomed Inc ($525.00) |
| 2023 | $20,245 | 77 | EDAP TECHNOMED INC ($18,482) |
| 2022 | $1,373 | 36 | Teleflex LLC ($623.63) |
| 2021 | $1,401 | 21 | EDAP TECHNOMED INC ($1,102) |
| 2020 | $686.56 | 29 | EDAP TECHNOMED INC ($228.02) |
| 2019 | $212.28 | 12 | PFIZER INC. ($46.00) |
| 2017 | $479.67 | 6 | Astellas Pharma US Inc ($224.85) |
All Payment Transactions
252 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/18/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $22.73 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/28/2024 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Continence Care | ||||||
| 10/23/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Diagnostic Imaging | ||||||
| 10/22/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/10/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Oncology | ||||||
| 10/02/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/23/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/19/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $16.68 | General |
| 09/11/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Oncology | ||||||
| 09/10/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: UROTHELIAL CANCER | ||||||
| 08/26/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Urology Gynecology | ||||||
| 08/21/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/12/2024 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Continence Care | ||||||
| 08/05/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: ONCOLOGY | ||||||
| 08/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: HORMONE THERAPY | ||||||
| 08/01/2024 | Baxter Healthcare | FLOSEAL (Biological) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: Surgical Care | ||||||
| 07/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 751 | 1,056 | $91,647 | $45,822 |
| 2022 | 11 | 693 | 956 | $80,573 | $40,762 |
| 2021 | 7 | 512 | 772 | $62,018 | $31,606 |
| 2020 | 7 | 412 | 602 | $57,537 | $26,416 |
Total Patients
2,368
Total Services
3,386
Medicare Billing
$144,606
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 131 | $22,532 | $11,866 | 52.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 54 | 63 | $20,638 | $11,301 | 54.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 133 | 180 | $20,983 | $10,552 | 50.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $11,320 | $5,174 | 45.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $4,756 | $1,904 | 40.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 156 | 231 | $6,898 | $1,666 | 24.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 203 | 331 | $1,629 | $1,293 | 79.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 12 | 12 | $1,801 | $1,282 | 71.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 29 | 39 | $1,092 | $783.30 | 71.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 141 | 206 | $24,013 | $12,602 | 52.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 45 | 50 | $16,379 | $9,271 | 56.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 56 | 61 | $10,492 | $5,264 | 50.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 65 | 65 | $11,449 | $4,950 | 43.2% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 13 | 13 | $4,550 | $2,255 | 49.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 15 | 15 | $2,251 | $1,669 | 74.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $4,043 | $1,605 | 39.7% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 182 | 321 | $1,579 | $1,246 | 78.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 119 | 156 | $4,658 | $1,062 | 22.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 29 | 41 | $1,148 | $833.76 | 72.6% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 13 | 13 | $10.40 | $5.16 | 49.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 111 | 185 | $21,565 | $12,246 | 56.8% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 34 | 34 | $11,138 | $6,131 | 55.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 51 | 51 | $8,983 | $4,088 | 45.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 33 | 40 | $6,880 | $3,663 | 53.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 29 | 29 | $7,805 | $3,260 | 41.8% |
About Dr. Fernando Caumont, MD
Dr. Fernando Caumont, MD is a Urology healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2017. The National Provider Identifier (NPI) number assigned to this provider is 1023533064.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fernando Caumont, MD has received a total of $26,312 in payments from pharmaceutical and medical device companies, with $1,914 received in 2024. These payments were reported across 252 transactions from 37 companies. The most common payment nature is "Consulting Fee" ($12,000).
As a Medicare-enrolled provider, Caumont has provided services to 2,368 Medicare beneficiaries, totaling 3,386 services with total Medicare billing of $144,606. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Rochester, NY
- Active Since 08/10/2017
- Last Updated 08/29/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1023533064
Products in Payments
- UROLIFT (Device) $810.59
- ERLEADA (Drug) $505.74
- PROVENGE (Drug) $371.55
- AQUABEAM ROBOTIC SYSTEM (Device) $271.06
- GEMTESA (Drug) $221.63
- JELMYTO (Drug) $208.10
- iTIND System (Device) $194.37
- XTANDI (Drug) $189.88
- ELIGARD (Drug) $173.49
- KEYTRUDA (Biological) $161.48
- CAMCEVI (Drug) $150.20
- LUPRON DEPOT (Drug) $143.51
- SpeediCath (Device) $135.95
- AQUABEAM SYSTEM (Device) $128.74
- Xtandi (Drug) $121.79
- Lupron (Drug) $114.82
- PROLARIS (Device) $103.40
- ORGOVYX (Drug) $102.15
- Myrbetriq (Drug) $94.01
- XIAFLEX (Biological) $87.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Rochester
Tobias Kohler, Md, MD
Urology — Payments: $176,600
Urology $176,600
Dr. Jonathan Warner, M.d, M.D
Urology — Payments: $149,347
Urology $149,347
Sevann Helo, M.d, M.D
Urology — Payments: $96,211
Urology $96,211
Ahmed Ghazi, Md, MD
Urology — Payments: $57,583
Urology $57,583
Stephen Boorjian, M.d, M.D
Urology — Payments: $47,998
Urology $47,998
Mr. John Valvo, Md, MD
Urology — Payments: $28,953
Urology $28,953